Posted inPosts

China’s genomics giant BGI seeks GEM listing

China’s genomics powerhouse BGI resumed Tuesday its application for a listing on the Growth Enterprises Market (GEM) board on the Shenzhen Stock Exchange, after being stuck in the country’s clogged pipeline for one year, local media is reporting. Earlier the genomics giant’s IPO review was suspended due to incomplete documents. If successful, the listing may […]